Use of Methazolamide to Lower Intraocular Pressure | NCT05498103 | Trialant

Use of Methazolamide to Lower Intraocular Pressure | NCT05498103 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Methazolamide 25 mg	Active Comparator	Once a day [q.d] in the morning for 1 week, Twice a day [b.i.d.] in the morning and evening for 1 week	Drug: Methazolamide 25 MG
Methazolamide 50 mg	Active Comparator	Once a day [q.d] in the morning for 1 week, Twice a day [b.i.d.] in the morning and evening for 1 week	Drug: Methazolamide 50 MG

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Percent IOP change at each follow-up Visit	IOP measure is measured using Goldmann Tonometry. IOP is measured in mmHg with a normal range from 12 mmHg to 22 mmHg.	Day 1 (Pre-dosing, then 4- and 8- hours post dosing), Day 7 (Pre-dosing, then 4- and 8- hours post dosing), Day 14 (Pre-dosing, then 4- and 8- hours post dosing)

Contacts/Locations Module

Submission Tracking

Intervention Browse Module